$1.71
+0.09 (+5.56%)
Open$1.66
Previous Close$1.62
Day High$1.72
Day Low$1.66
52W High$4.56
52W Low$1.48
Volume—
Avg Volume510.1K
Market Cap114.17M
P/E Ratio—
EPS$-0.69
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+532.2% upside
Current
$1.71
$1.71
Target
$10.81
$10.81
$7.63
$10.81 avg
$13.89
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 627.2K | 545.5K | 16.05M |
| Net Income | -48,345,854 | -37,839,176 | -3,462,613 |
| Profit Margin | -7,732.0% | -7,345.4% | -21.6% |
| EBITDA | -51,235,329 | -42,328,517 | -3,307,317 |
| Free Cash Flow | — | — | -2,137,974 |
| Rev Growth | +15.0% | +15.0% | +0.8% |
| Debt/Equity | — | — | 0.67 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $214.98 | -1.15% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.28 | +0.41% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $140.30 | +0.67% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $447.26 | +0.16% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $777.25 | +0.60% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.73 | -0.65% | 139.7 | 43.84B |